Nicolas Poirier

Nicolas Poirier

Company: OSE Immunotherapeutics

Job title: Chief Scientific Officer


Exploring an Optimized Anti-PD1 Bispecific Immunocytokine Platform & Interest of IL-7 12:30 pm

• See how the BiCKI monovalent anti-PD1 platform has been optimized for manufacturing and pharmacokinetics of innovative bispecific fusion proteins • Delve into the key roles of the valency and affinity of fused cytokines • Demonstrate significant preclinical efficacy of anti-PD1/IL-7 bispecific in syngeneic immunocompetent or humanized mice modelsRead more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.